Clozapine is a bit of a "heavy hitter" in psychiatry—it's often the last resort, but it can be absolutely life-changing for patients who haven't responded to other treatments. Since you're prepping for the UKMLA AKT, this is a high-yield topic because the monitoring requirements are so strict.

Let's start by pulling up some key lessons on this to make sure we cover all the bases.

The main indication for Clozapine is Treatment-Resistant Schizophrenia. In the UK, this is defined as schizophrenia that hasn't responded to at least two other antipsychotics (one of which must be an atypical/second-generation antipsychotic) used for an adequate duration at an adequate dose.

It's also used for patients with schizophrenia who have persistent, high-risk suicidal behavior.

While it's effective, the side effect profile is what makes it so tricky to manage. I've put together a table of the most critical side effects and the monitoring requirements you'll need to know for your exams.

One of the most common "gotcha" questions on the AKT is about hypersalivation (sialorrhea). It's very common with clozapine, and we often treat it with hyoscine hydrobromide or atropine drops (off-label).

Another critical point is the blood monitoring protocol. We use a "traffic light" system (Green, Amber, Red) to decide if it's safe to continue the medication. Let me find a visual for that so you can see the thresholds.